Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
SIGA Technologies Inc
NASDAQ SIGA
Data sourced from
and
and
SIGA Technologies Inc Net Income Margin for the year ending December 31, 2023
SIGA Technologies Inc Net Income Margin is NA for the year ending December 31, 2023. Net Income Margin reflects the percentage of revenue that represents net income, indicating the overall profitability of a company.
-
SIGA Technologies Inc Net Income Margin for the year ending December 31, 2022 was 30.61%, a -41.09% change year over year.
-
SIGA Technologies Inc Net Income Margin for the year ending December 31, 2021 was 51.96%, a 15.23% change year over year.
-
SIGA Technologies Inc Net Income Margin for the year ending December 31, 2020 was 45.09%, a 266.51% change year over year.
-
SIGA Technologies Inc Net Income Margin for the year ending December 31, 2019 was -27.08%, a -130.62% change year over year.
Don’t Miss A Beat
Looking to stay ahead of the competition and stay informed? Receive your daily dose of market news, trends, and analysis to kickstart your day and stay up-to-date.
NASDAQ: SIGA
| CEO | Dr. Phillip Louis Gomez III, M.D., Ph.D. |
| IPO Date | Sept. 9, 1997 |
| Location | United States |
| Headquarters | 31 East 62nd Street, New York, NY, United States, 10065 |
| Employees | 45 |
| Sector | Healthcare |
| Industry | Drug manufacturers - specialty & generic |
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Key trends
Similar companies
Catalent Inc
NA
NA
Phibro Animal Health Corporation
NA
NA
StockViz Staff
September 20, 2024
Any question? Send us an email